Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas

被引:225
作者
Hodgson G. [1 ]
Hager J.H. [3 ]
Volik S. [1 ]
Hariono S. [1 ]
Wernick M. [1 ]
Moore D. [1 ]
Albertson D.G. [1 ,2 ]
Pinkel D. [1 ,2 ]
Collins C. [1 ,2 ]
Hanahan D. [3 ]
Gray J.W. [1 ,2 ]
机构
[1] 1Cancer Genetics and Breast Oncology, UCSF Cancer Center, University of California at San Francisco, San Francisco
[2] Department of Laboratory Medicine, University of California at San Francisco, San Francisco, CA 94143-0808
[3] Department of Biochemistry and Biophysics, UCSF Diabetes and Comprehensive Cancer Centers, University of California at San Francisco, San Francisco
关键词
D O I
10.1038/ng771
中图分类号
学科分类号
摘要
Carcinomas that develop in the pancreatic islets of transgenic mice expressing the SV40 T-antigens (Tag) under transcriptional control of the rat insulin II promoter (RIP) progress through well-characterized stages that are similar to aspects of human tumor progression, including hyperplastic growth, increased angiogenesis and reduced apoptosis. The latter two stages have been associated with recurrent loss of heterozygosity (LOH) and reduced genome copy number on chromosomes 9 (LOH9) and 16 (LOH16), aberrations which we believe contribute to these phenotypes. Earlier analyses localized LOH9 to approximately 3 Mb and LOH16 to approximately 30 Mb (both syntenic with human 3q21-q25) but were limited by low throughput and a lack of informative polymorphic markers. Here we show that comparative genomic hybridization to DNA microarrays (array CGH) overcomes these limitations by allowing efficient, genome-wide analyses of relative genome copy number. The CGH arrays used in these experiments carried BACs distributed at 2-20-MB intervals across the mouse genome and at higher density in regions of interest. Using array CGH, we further narrowed the loci for LOH9 and LOH16 and defined new or previously unappreciated recurrent regions of copy-number decrease on chromosomes 6, 8 and 14 (syntenic with human chromosomes 12p11-p13, 16q24.3 and 13q11-q32, respectively) and regions of copy-number increase on chromosomes 2 and 4 (syntenic to human chromosomes 20q13.2 and 1p32-p36, respectively). Our analyses of human genome sequences syntenic to these regions suggest that CYP24, PFDN4, STMN1, CDKN1B, PPP2R3 and FSTL1 are candidate oncogenes or tumor-suppressor genes. We also show that irradiation and genetic background influence the spectrum of aberrations present in these tumors. © 2001 Nature Publishing Group.
引用
收藏
页码:459 / 464
页数:5
相关论文
共 25 条
  • [1] Dietrich W.F., Et al., Genome-wide search for loss of heterozygosity in transgenic mouse tumors reveals candidate tumor suppressor genes on chromosomes 9 and 16, Proc. Natl. Acad. Sci. USA, 91, pp. 9451-9455, (1994)
  • [2] Parangi S., Dietrich W., Christofori G., Lander E.S., Hanahan D., Tumor suppressor loci on mouse chromosomes 9 and 16 are lost at distinct stages of tumorigenesis in a transgenic model of islet cell carcinoma, Cancer Res., 55, pp. 6071-6076, (1995)
  • [3] Shi Y.P., Et al., DNA copy number changes associated with characteristic LOH in islet cell carcinomas of transgenic mice, Genes Chromosom. Cancer, 19, pp. 104-111, (1997)
  • [4] Pinkel D., Et al., High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays, Nature Genet., 20, pp. 207-211, (1998)
  • [5] Pollack J.R., Et al., Genome-wide analysis of DNA copy-number changes using cDNA microarrays, Nature Genet., 23, pp. 41-46, (1999)
  • [6] Solinas-Toldo S., Et al., Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalances, Genes Chromosomes Cancer, 20, pp. 399-407, (1997)
  • [7] Heiskanen M.A., Et al., Detection of gene amplification by genomic hybridization to cDNA microarrays, Cancer Res., 60, pp. 799-802, (2000)
  • [8] Telenius H., Et al., Degenerate oligonucleotide-primed PCR: General amplification of target DNA by a single degenerate primer, Genomics, 13, pp. 718-725, (1992)
  • [9] Lander E.S., Et al., Initial sequencing and analysis of the human genome, Nature, 409, pp. 860-921, (2001)
  • [10] Venter J.C., Et al., The sequence of the human genome, Science, 291, pp. 1304-1351, (2001)